神華(01088.HK)預告上半年利潤按年跌16%至204億人幣
中國神華(01088.HK)公布今年上半年業績預告,經初步測算,預計今年上半年利潤約為204億元人民幣(下同),按年下降約16%。
集團指,利潤下降主因受新冠肺炎疫情對經濟需求側的影響,集團煤炭、電力、煤化工產品的銷售量及鐵路運輸周轉量下降,以及煤炭、煤化工產品平均銷售價格下降;及去年1月31日組建合資公司交易完成交割的影響(包括去年上半年的淨利潤包含公司所出資電廠於去年1月產生的利潤;及交割日確認一次性投資收益11.21億元的基數效應)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.